Created in 2000 (Switzerland), AERINAZE own 402 sister brands and 17477 competing brands. The AERINAZE brand is owned by Merck & Co, a company listed in New York. AERINAZE belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Merck & Co
(AERINAZE)
over 5 years*
USD 221.47